Filter Results:
(531)
Show Results For
- All HBS Web
(1,018)
- People (2)
- News (263)
- Research (531)
- Events (6)
- Multimedia (4)
- Faculty Publications (185)
Show Results For
- All HBS Web
(1,018)
- People (2)
- News (263)
- Research (531)
- Events (6)
- Multimedia (4)
- Faculty Publications (185)
Sort by
- 14 Dec 2020
- Research & Ideas
What Does December's Drug-Approval Dash Mean for COVID-19 Vaccines?
Pharmaceutical regulators around the world tend to speed through drug applications in December and before major national holidays, according to new research that might raise questions about COVID-19 vaccines and other treatments under... View Details
- January–February 2023
- Article
Data-Driven COVID-19 Vaccine Development for Janssen
By: Dimitris Bertsimas, Michael Lingzhi Li, Xinggang Liu, Jennings Xu and Najat Khan
The COVID-19 pandemic has spurred extensive vaccine research worldwide. One crucial part of vaccine development is the phase III clinical trial that assesses the vaccine for safety and efficacy in the prevention of COVID-19. In this work, we enumerate the first... View Details
Keywords: COVID-19; Health Testing and Trials; Forecasting and Prediction; AI and Machine Learning; Research; Pharmaceutical Industry
Bertsimas, Dimitris, Michael Lingzhi Li, Xinggang Liu, Jennings Xu, and Najat Khan. "Data-Driven COVID-19 Vaccine Development for Janssen." INFORMS Journal on Applied Analytics 53, no. 1 (January–February 2023): 70–84.
- 14 Apr 2021
- Research & Ideas
The High Cost of the Slow COVID Vaccine Rollout
Government officials should have poured much more money into producing and distributing COVID-19 vaccines to save more lives and rescue the economy faster, according to new research co-authored by 16 View Details
- Research Summary
Overview
Dr. Burch’s research focuses on capitalism, work, and gender in the twentieth-century United States. Her work reinterprets the history of direct selling by placing it at the center, rather than on the margins, of narratives about advanced capitalism. Examining the... View Details
- Research Summary
Emotional Experience, Expression, and Regulation
Once considered irrational, emotions often exert a more profound influence on decision-making and workplace outcomes than logic or reason. Professor Brooks studies emotional experience, emotional expression, and how individuals can regulate their emotions... View Details
- 13 Aug 2018
- Research & Ideas
Women Heart Patients Have Better Survival Odds with Women Doctors
their doctor is also a woman, the study published this month in the Proceedings of the National Academy of Sciences shows. Researchers looked at about 582,000 census records of patients admitted to Florida emergency rooms from 1991 to... View Details
- 06 Aug 2014
- Research & Ideas
Climbing Down from the Ivory Tower
entirely on faraway academics and organizations to solve local problems. This frustrates Ashraf, who for more than a decade has studied behavioral economics in the context of developing countries. She believes that global health View Details
- 15 Dec 2020
- Research & Ideas
The Unspoken Messages of COVID-19 Restrictions
fact, Harvard University research suggests that reopening restaurants last spring, shortly after the pandemic’s first wave, may have led some people to assume that eating out was safe—despite the now-documented links between indoor dining... View Details
- 25 Apr 2017
- First Look
First Look at New Research, April 25
research typically prescribes task sequences implemented by managers. Yet employees often have discretion to deviate from their prescribed sequence. Using data from 2.4 million radiological diagnoses, we find that doctors prioritize... View Details
Keywords: Sean Silverthorne
- 27 Aug 2012
- Research & Ideas
Employee-Suggestion Programs That Work
through the cracks.” Fixing By Walking Around The program the researchers tested was modeled on Allan Frankel's "Leadership WalkRounds," which has been shown to improve safety in various medical facilities.... View Details
Keywords: by Paul Guttry
- May 2023 (Revised June 2023)
- Case
Novartis (A): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Care and Treatment; Business Model; Leadership; Pharmaceutical Industry; Switzerland
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (A): Reimagining Medicine." Harvard Business School Case 723-443, May 2023. (Revised June 2023.)
- 20 Jul 2010
- First Look
First Look: July 20
Chairman Liu Jia wondered what that meant for his 15-year-old dental clinic business. Founded in 1993, Jiamei Dental Medical Management Group ("Jiamei") rode the wave of China's rapid economic development and had become China's... View Details
Keywords: Martha Lagace
- 12 May 2016
- Research & Ideas
When Mass Shootings Lead to Looser Gun Restrictions
In the United States, there’s much debate over whether gun-related legislation can diminish the likelihood of mass shootings. New research from Harvard Business School turns the question on its head: Do mass shootings lead to more... View Details
Keywords: by Carmen Nobel
- 20 Sep 2011
- First Look
First Look: September 20
applying project management principles to medical research. The resulting innovation, Integrative Research Centers, are novel in this field and present a substantial challenge to the Institute's culture,... View Details
Keywords: Sean Silverthorne
- 06 Sep 2022
- Research & Ideas
Curbing an Unlikely Culprit of Rising Drug Prices: Pharmaceutical Donations
Prescription drug costs continue to climb in the United States, but tightening a loophole in a federal law may help curb rising expenses, according to research published this week in Health Affairs. Efforts to control US health care... View Details
- May 2023 (Revised June 2023)
- Supplement
Novartis (C): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Testing and Trials; Health Care and Treatment; Business Model; Problems and Challenges; Pharmaceutical Industry; Switzerland
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (C): Reimagining Medicine." Harvard Business School Supplement 723-445, May 2023. (Revised June 2023.)
- November 1997 (Revised July 1999)
- Case
Guidant: Cardiac Rhythm Management Business (A)
By: Steven C. Wheelwright and Mikelle Eastley
Examines the choices Guidant must make in research and development spending and new product development. More specifically, CEO Jay Graf considers the payoffs and tradeoffs of using product development skills that he learned in CPI's core business when applied to a... View Details
Keywords: Marketing Strategy; Product Marketing; Product Development; Business or Company Management; Management Skills; Research and Development; Business Strategy; Communication; Product Design; Market Design; Organizational Design; Medical Devices and Supplies Industry
Wheelwright, Steven C., and Mikelle Eastley. "Guidant: Cardiac Rhythm Management Business (A)." Harvard Business School Case 698-021, November 1997. (Revised July 1999.)
- 09 May 2018
- Research & Ideas
A Simple Way for Restaurant Inspectors to Improve Food Safety
new research about how scheduling affects worker behavior. The potential result: Americans could avoid 19 million foodborne illnesses, nearly 51,000 hospitalizations, and billions of dollars of related View Details
- 26 Nov 2012
- Research & Ideas
New Winners and Losers in the Internet Economy
study was directed by John A. Deighton, the Harold M. Brierley Professor of Business Administration at Harvard Business School. The study's principal investigator was HBS research associate Leora D. Kornfeld. "In a very flat economy,... View Details
- 14 Dec 2021
- Op-Ed
To Change Your Company's Culture, Don't Start by Trying to Change the Culture
something you fix Consider Vince Forlenza’s experience, as former CEO of medical technology maker Becton Dickinson, in developing a more innovative culture to meet the changing competitive landscape. He recently told me, “The barrier that... View Details
Keywords: by Michael Beer